Gabrielle Pilcer

1.7k total citations · 1 hit paper
21 papers, 1.4k citations indexed

About

Gabrielle Pilcer is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Food Science. According to data from OpenAlex, Gabrielle Pilcer has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Pharmaceutical Science and 5 papers in Food Science. Recurrent topics in Gabrielle Pilcer's work include Inhalation and Respiratory Drug Delivery (14 papers), Drug Solubulity and Delivery Systems (6 papers) and Microencapsulation and Drying Processes (5 papers). Gabrielle Pilcer is often cited by papers focused on Inhalation and Respiratory Drug Delivery (14 papers), Drug Solubulity and Delivery Systems (6 papers) and Microencapsulation and Drying Processes (5 papers). Gabrielle Pilcer collaborates with scholars based in Belgium, Austria and United States. Gabrielle Pilcer's co-authors include Karim Amighi, Francis Vanderbist, Nathalie Wauthoz, Thami Sebti, F. J. Stauffer, Valérie Vanhoorne, Thomas De Beer, Chris Vervaet, Pierre-François Chavez and Karl Traina and has published in prestigious journals such as Advanced Drug Delivery Reviews, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Gabrielle Pilcer

21 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Formulation strategy and use of excipients in pulmonary drug delivery

2010 601 citations Gabrielle Pilcer, Karim Amighi International Journal of Pharmaceutics profile →

Peers

Countries citing papers authored by Gabrielle Pilcer

Since Specialization

Citations

This map shows the geographic impact of Gabrielle Pilcer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabrielle Pilcer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabrielle Pilcer more than expected).

Fields of papers citing papers by Gabrielle Pilcer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabrielle Pilcer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabrielle Pilcer. The network helps show where Gabrielle Pilcer may publish in the future.

Co-authorship network of co-authors of Gabrielle Pilcer

This figure shows the co-authorship network connecting the top 25 collaborators of Gabrielle Pilcer. A scholar is included among the top collaborators of Gabrielle Pilcer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabrielle Pilcer. Gabrielle Pilcer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sampling and diversion strategy for twin-screw granulation lines using batch statistical process monitoring 2022 ·European Journal of Pharmaceutical Sciences ·F. J. Stauffer, (unknown), Gabrielle Pilcer	7
2	Model-Guided Development of a Semi-Continuous Drying Process 2022 ·Pharmaceutical Research ·(unknown), Matej Zadravec, Johan Remmelgas, Thomas Forgber, (unknown), Gabrielle Pilcer, F. J. Stauffer, (unknown)	4
3	Managing API raw material variability during continuous twin-screw wet granulation 2019 ·International Journal of Pharmaceutics ·F. J. Stauffer, Valérie Vanhoorne, Gabrielle Pilcer, Pierre-François Chavez, Chris Vervaet, Thomas De Beer	23
4	Managing API raw material variability in a continuous manufacturing line – Prediction of process robustness 2019 ·International Journal of Pharmaceutics ·F. J. Stauffer, Valérie Vanhoorne, Gabrielle Pilcer, Pierre-François Chavez, Chris Vervaet, Thomas De Beer	22
5	Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing 2018 ·European Journal of Pharmaceutics and Biopharmaceutics ·F. J. Stauffer, Valérie Vanhoorne, Gabrielle Pilcer, (unknown), (unknown), Mario Schubert, Luc Aerts, Thomas De Beer	39
6	Managing active pharmaceutical ingredient raw material variability during twin-screw blend feeding 2018 ·European Journal of Pharmaceutics and Biopharmaceutics ·F. J. Stauffer, Valérie Vanhoorne, Gabrielle Pilcer, Pierre-François Chavez, Mario Schubert, Chris Vervaet, Thomas De Beer	22
7	Inflammation induced by inhaled lipopolysaccharide depends on particle size in healthy volunteers 2016 ·British Journal of Clinical Pharmacology ·Virginie Doyen, Gabrielle Pilcer, (unknown), Francis Corazza, Alfred Bernard, Pierre Bergmann, Nicolas Lefèvre, Karim Amighi, Olivier Michel	7
8	Inhaled proteins: Challenges and perspectives 2013 ·International Journal of Pharmaceutics ·(unknown), Gabrielle Pilcer, Karim Amighi	110
9	New Co-Spray-Dried Tobramycin Nanoparticles-Clarithromycin Inhaled Powder Systems for Lung Infection Therapy in Cystic Fibrosis Patients 2013 ·Journal of Pharmaceutical Sciences ·Gabrielle Pilcer, Rémi Rosière, Karl Traina, Thami Sebti, Francis Vanderbist, Karim Amighi	38
10	Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis 2013 ·International Journal of Pharmaceutics ·Gabrielle Pilcer, (unknown), Karl Traina, Hamidou Traore, Thami Sebti, Francis Vanderbist, Karim Amighi	27
11	Lactose characteristics and the generation of the aerosol 2011 ·Advanced Drug Delivery Reviews ·Gabrielle Pilcer, Nathalie Wauthoz, Karim Amighi	172
12	Comparative pharmacoscintigraphic and pharmacokinetic evaluation of two new formulations of inhaled insulin in type 1 diabetic patients 2011 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Agnès Burniat, Didier Blocklet, Simon Lacroix, Miriam Cnop, Françoise Féry, (unknown), Gabrielle Pilcer, Michel Deleers, Serge Goldman, Karim Amighi	16
13	Formulation strategy and use of excipients in pulmonary drug delivery breakdown → 2010 ·International Journal of Pharmaceutics ·Gabrielle Pilcer, Karim Amighi	601
14	Pharmacoscintigraphic and pharmacokinetic evaluation on healthy human volunteers of sustained-release floating minitablets containing levodopa and carbidopa 2008 ·International Journal of Pharmaceutics ·Jonathan Goole, (unknown), Gabrielle Pilcer, (unknown), Didier Blocklet, Serge Goldman, Massimo Pandolfo, Francis Vanderbist, Karim Amighi	17
15	Spray‐dried carrier‐free dry powder tobramycin formulations with improved dispersion properties 2008 ·Journal of Pharmaceutical Sciences ·Gabrielle Pilcer, Francis Vanderbist, Karim Amighi	29
16	Correlations between cascade impactor analysis and laser diffraction techniques for the determination of the particle size of aerosolised powder formulations 2008 ·International Journal of Pharmaceutics ·Gabrielle Pilcer, Francis Vanderbist, Karim Amighi	45
17	Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery 2008 ·International Journal of Pharmaceutics ·Gabrielle Pilcer, Francis Vanderbist, Karim Amighi	50
18	Pharmacoscintigraphic and pharmacokinetic evaluation of tobramycin DPI formulations in cystic fibrosis patients 2007 ·European Journal of Pharmaceutics and Biopharmaceutics ·Gabrielle Pilcer, Jonathan Goole, (unknown), Didier Blocklet, Christiane Knoop, Francis Vanderbist, Karim Amighi	27
19	Formulation and Characterization of Lipid-Coated Tobramycin Particles for Dry Powder Inhalation 2006 ·Pharmaceutical Research ·Gabrielle Pilcer, Thami Sebti, Karim Amighi	85
20	Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation 2006 ·European Journal of Pharmaceutics and Biopharmaceutics ·Thami Sebti, Gabrielle Pilcer, (unknown), Serge Goldman, Alain Michils, Francis Vanderbist, Karim Amighi	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact